Research & Development

The Enzymatica Research Journey

Enzymatica is a leader in enzyme science.

From discovery to development, Enzymatica has been asking ‘how can trypsin enzymes affect greater patient care?’ This pursuit and long-term commitment has led to a healthcare innovation that will change the way we think about and approach upper respiratory health.

This has led to a technology platform with a post-pandemic global significance due to its ability to help the human body protect itself from airborne viruses such as those that cause the common cold.

Enzymatica’s research has pursued a path to validate trypsin’s full potential to bring proven health-protection people can easily use and trust in their daily lives.

Enzymatica describes this as `The Science That Protects`.

Backed by years of research, Enzymatica’s unique enzyme science has been developed throughout a testing programme spanning 3 stages and involving both laboratory-based and real-world usage evidence.